Seven Eight Capital LP cut its position in shares of Agilent Technologies, Inc. (NYSE:A) by 75.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,606 shares of the medical research company’s stock after selling 29,500 shares during the quarter. Seven Eight Capital LP’s holdings in Agilent Technologies were worth $570,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of the business. Jennison Associates LLC purchased a new stake in shares of Agilent Technologies in the second quarter worth approximately $212,000. Skandinaviska Enskilda Banken AB publ lifted its position in shares of Agilent Technologies by 5.7% in the first quarter. Skandinaviska Enskilda Banken AB publ now owns 64,834 shares of the medical research company’s stock worth $3,428,000 after purchasing an additional 3,489 shares in the last quarter. Commerce Bank purchased a new stake in shares of Agilent Technologies in the second quarter worth approximately $1,242,000. Delta Lloyd Asset Management N.V. purchased a new stake in shares of Agilent Technologies in the second quarter worth approximately $2,026,000. Finally, Cipher Capital LP lifted its position in shares of Agilent Technologies by 18.1% in the second quarter. Cipher Capital LP now owns 89,523 shares of the medical research company’s stock worth $5,309,000 after purchasing an additional 13,703 shares in the last quarter.
A number of analysts have recently issued reports on A shares. Deutsche Bank AG reissued a “buy” rating and issued a $66.00 price target on shares of Agilent Technologies in a research report on Thursday, June 22nd. Morgan Stanley increased their price target on shares of Agilent Technologies from $65.00 to $70.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 24th. Jefferies Group LLC reissued a “buy” rating and issued a $66.00 price target on shares of Agilent Technologies in a research report on Wednesday, August 9th. BTIG Research increased their price target on shares of Agilent Technologies from $57.00 to $65.00 and gave the stock a “buy” rating in a research report on Wednesday, May 24th. Finally, BidaskClub lowered shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $63.91.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://ledgergazette.com/2017/09/17/seven-eight-capital-lp-has-570000-holdings-in-agilent-technologies-inc-a.html.
In other news, insider Patrick Kaltenbach sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, July 13th. The stock was sold at an average price of $61.26, for a total transaction of $306,300.00. Following the sale, the insider now owns 45,138 shares in the company, valued at approximately $2,765,153.88. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Michael R. Mcmullen sold 16,492 shares of the company’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $65.33, for a total value of $1,077,422.36. Following the sale, the chief executive officer now owns 211,872 shares in the company, valued at approximately $13,841,597.76. The disclosure for this sale can be found here. Insiders sold a total of 155,165 shares of company stock worth $9,768,409 in the last 90 days.
Agilent Technologies, Inc. (A) opened at 65.96 on Friday. The company has a 50-day moving average price of $62.40 and a 200-day moving average price of $58.01. Agilent Technologies, Inc. has a 12-month low of $42.92 and a 12-month high of $66.42. The firm has a market cap of $21.23 billion, a P/E ratio of 34.02 and a beta of 1.30.
Agilent Technologies (NYSE:A) last released its earnings results on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.07. The firm had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.49 EPS. On average, analysts predict that Agilent Technologies, Inc. will post $2.32 earnings per share for the current year.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.